Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis

Area of Science:

• Neuroimmunology
• Endocrinology
• Gastroenterology

Background:

• Adrenal glands modulate immune responses via neuroimmunoendocrine pathways and cortisol.
• Glucocorticoids (GC) can suppress inflammation, relevant to inflammatory bowel disease (IBD).

Purpose of the Study:

• To investigate the role of adrenal glands in experimental colitis.
• To determine the impact of adrenalectomy and GC replacement on colitis severity and immune markers.

Main Methods:

• Induction of experimental colitis using dextran sulfate sodium (DSS) in C57BL/6 mice.
• Surgical adrenalectomy with or without glucocorticoid (GC) replacement.
• Assessment of clinical scores, systemic cytokine levels (IL-6, LPS), and gut immune cell populations (dendritic cells, IFN-γ, FasL).

Main Results:

• Adrenalectomy exacerbated colitis, increasing clinical scores and IL-6, while decreasing LPS.
• Adrenalectomy altered systemic regulatory markers and gut immune infiltrates, including increased tolerogenic dendritic cells but no local corticosterone.
• Glucocorticoid replacement in adrenalectomized mice restored markers to levels seen in the DSS-only group.

Conclusions:

• Adrenal-derived hormones, especially GC, play a critical role in modulating gut immune responses during colitis.
• Adrenalectomy impacts systemic regulatory markers and local gut inflammation, highlighting neuroimmunoendocrine mechanisms in IBD.
• These findings provide insights into the mechanisms underlying colitis and the therapeutic potential of adrenal hormones.